Aprogen Biologics Inc. (KRX: 003060)

Market Cap	140.67B
Revenue (ttm)	73.64B
Net Income (ttm)	-131.14B
Shares Out	197.57M
EPS (ttm)	-1,977.60
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	329,999
Open	717.00
Previous Close	721.00
Day's Range	704.00 - 735.00
52-Week Range	704.00 - 3,330.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 14, 2024

About Aprogen Biologics

Aprogen Biologics Inc. manufactures and sells pharmaceutical products primarily in South Korea. It offers approximately 200 types of medicines, including ethical and over the counter drugs. The company offers its drugs for transfusion, digestive system, osteoarthritis, skeletal muscle relaxants, NSAIDs, osteoporosis, circulatory system, endocrine, respiratory system, urinary system, depilatory, antihistamines and antiallergics, obesity, brain function, neurologics, and male pattern hair loss. It also provides anti-biotic, anti-fungal, anti-vira...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1960
• Employees: 377
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 003060